| Name | Title | Contact Details |
|---|
Discount Development Svc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
Stormont Vail Health is a nonprofit integrated health care system that has been serving the health care needs of northeast Kansas for more than 130 years. It is comprised of Stormont Vail Hospital, a 586-bed acute care Magnet®-designated hospital, and Cotton O`Neil Clinic, a multi-specialty physician group with more than 250 physicians. Nearly 5,000 employees provide care and support services for patients in the hospital and 35 other locations, including the Cotton O`Neil Heart Center, Cancer Center, Diabetes & Endocrinology Center, Digestive Health Center, Pediatrics clinics, 10 regional primary care clinics and six Express Care clinics. Stormont Vail Health is committed to its mission of improving the health of the community by being a national leader in providing compassionate, high-quality and efficient integrated care through collaboration that results in a healthier community. Stormont Vail Health is a member of the Mayo Clinic Care Network, a group of more than 40 health care organizations who have joined together to complement their local expertise with the knowledge and experience of Mayo Clinic health care professionals. Stormont Vail`s local partnerships include housing the Bachelor of Science in Nursing program of the Baker University School of Nursing, providing athletic training services to Washburn University Athletics and being a founding partner of the Powercat Health Partnership with Kansas State University and the Kansas Health Foundation.
Avivia Health From Kaiser Permanente is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.